Loading...
Omega Therapeutics (OMGAQ, $0.02) was a top loser over the last three months, falling -5 to $0.02 per share. A.I.dvisor analyzed 809 stocks in the Biotechnology Industry for the 3-month period ending August 1, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.